Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Mod Pathol. 2010 Jan 15;23(5):743–750. doi: 10.1038/modpathol.2009.189

Figure 4.

Figure 4

Distribution of mean (+/- SEM) immunostaining reactivities for CA I, CA II, CA IX, and CA XII in GISTs and other mesenchymal tumors. The strongest immunoreactivities were observed for CA II in GISTs. LM = leiomyoma, LMS = leiomyosarcoma, DES = desmoid tumor.